Brind.

Mylan plans to sell up to 92 million shares in Biocon.

1 report, 1 independent Updated Jul 14
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Mylan plans to sell up to 92 million shares in Biocon.

Who's involved

What this event is mainly about
BioconMylan

Keep exploring

The entities involved

  • Biocon

    an Indian biopharmaceutical company

    Nothing else this week.

  • Mylan

    former pharmaceutical company

    Nothing else this week.

Coverage

Newest first; wire copies grouped